Qiu LX - Search Results

1

Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.

Qiu LX, Yao L, Mao C, Yu KD, Zhan P, Chen B, Yuan H, Zhang J, Xue K, Hu XC. Qiu LX, et al. Breast Cancer Res Treat. 2010 Jul;122(2):521-5. doi: 10.1007/s10549-009-0731-4. Epub 2010 Jan 7. Breast Cancer Res Treat. 2010. PMID: 20054636 Review.

2

Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects.

Qiu LX, Yuan H, Yu KD, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC. Qiu LX, et al. Breast Cancer Res Treat. 2010 Jun;121(3):703-8. doi: 10.1007/s10549-009-0636-2. Epub 2009 Nov 21. Breast Cancer Res Treat. 2010. PMID: 19936916

3

MnSOD Val16Ala polymorphism and prostate cancer susceptibility: a meta-analysis involving 8,962 subjects.

Mao C, Qiu LX, Zhan P, Xue K, Ding H, Du FB, Li J, Chen Q. Mao C, et al. Among authors: qiu lx. J Cancer Res Clin Oncol. 2010 Jul;136(7):975-9. doi: 10.1007/s00432-009-0742-x. Epub 2009 Dec 10. J Cancer Res Clin Oncol. 2010. PMID: 20012093

4

Lack of association between CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis of 22,090 cases and 28,498 controls.

Mao C, Wang XW, He BF, Qiu LX, Liao RY, Luo RC, Chen Q. Mao C, et al. Among authors: qiu lx. Breast Cancer Res Treat. 2010 Jul;122(1):259-65. doi: 10.1007/s10549-009-0695-4. Epub 2009 Dec 24. Breast Cancer Res Treat. 2010. PMID: 20033766

5

Current evidence on the relationship between polymorphisms in the COX-2 gene and breast cancer risk: a meta-analysis.

Yu KD, Chen AX, Yang C, Qiu LX, Fan L, Xu WH, Shao ZM. Yu KD, et al. Among authors: qiu lx. Breast Cancer Res Treat. 2010 Jul;122(1):251-7. doi: 10.1007/s10549-009-0688-3. Epub 2009 Dec 24. Breast Cancer Res Treat. 2010. PMID: 20033767

6

XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis.

Qiu LX, Mao C, Yao L, Yu KD, Zhan P, Chen B, Liu HG, Yuan H, Zhang J, Xue K, Hu XC. Qiu LX, et al. Breast Cancer Res Treat. 2010 Jul;122(2):489-93. doi: 10.1007/s10549-009-0726-1. Epub 2010 Jan 5. Breast Cancer Res Treat. 2010. PMID: 20049524 Review.

7

IGFBP3 A-202C polymorphism and breast cancer susceptibility: a meta-analysis involving 33,557 cases and 45,254 controls.

Qiu LX, Yao L, Yuan H, Mao C, Chen B, Zhan P, Xue K, Zhang J, Hu XC. Qiu LX, et al. Breast Cancer Res Treat. 2010 Aug;122(3):867-71. doi: 10.1007/s10549-010-0739-9. Epub 2010 Jan 19. Breast Cancer Res Treat. 2010. PMID: 20084546

8

The association between TA-repeat polymorphism in the promoter region of UGT1A1 and breast cancer risk: a meta-analysis.

Yao L, Qiu LX, Yu L, Yang Z, Yu XJ, Zhong Y, Yu L. Yao L, et al. Among authors: qiu lx. Breast Cancer Res Treat. 2010 Aug;122(3):879-82. doi: 10.1007/s10549-010-0742-1. Epub 2010 Jan 20. Breast Cancer Res Treat. 2010. PMID: 20087647

9

The association between ERCC2 Asp312Asn polymorphism and breast cancer risk: a meta-analysis involving 22,766 subjects.

Yao L, Qiu LX, Yu L, Yang Z, Yu XJ, Zhong Y, Hu XC, Yu L. Yao L, et al. Among authors: qiu lx. Breast Cancer Res Treat. 2010 Aug;123(1):227-31. doi: 10.1007/s10549-010-0754-x. Epub 2010 Feb 2. Breast Cancer Res Treat. 2010. PMID: 20127278

10

XRCC2 Arg188His polymorphism is not directly associated with breast cancer risk: evidence from 37,369 subjects.

Yu KD, Chen AX, Qiu LX, Fan L, Yang C, Shao ZM. Yu KD, et al. Among authors: qiu lx. Breast Cancer Res Treat. 2010 Aug;123(1):219-25. doi: 10.1007/s10549-010-0753-y. Epub 2010 Feb 2. Breast Cancer Res Treat. 2010. PMID: 20127279

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters